171 related articles for article (PubMed ID: 10673999)
1. Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST).
Voogd AC; Peterse JL; Crommelin MA; Rutgers EJ; Botke G; Elkhuizen PH; van Geel AN; Hoekstra CJ; van Pel R; van de Vijver MJ; Coebergh JW
Eur J Cancer; 1999 Dec; 35(13):1828-37. PubMed ID: 10673999
[TBL] [Abstract][Full Text] [Related]
2. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
[TBL] [Abstract][Full Text] [Related]
3. Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy.
Sinn HP; Anton HW; Magener A; von Fournier D; Bastert G; Otto HF
Eur J Cancer; 1998 Apr; 34(5):646-53. PubMed ID: 9713268
[TBL] [Abstract][Full Text] [Related]
4. Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?
Vrieling C; Collette L; Fourquet A; Hoogenraad WJ; Horiot JC; Jager JJ; Bing Oei S; Peterse HL; Pierart M; Poortmans PM; Struikmans H; Van den Bogaert W; Bartelink H;
Eur J Cancer; 2003 May; 39(7):932-44. PubMed ID: 12706362
[TBL] [Abstract][Full Text] [Related]
5. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
[TBL] [Abstract][Full Text] [Related]
6. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials.
Voogd AC; Nielsen M; Peterse JL; Blichert-Toft M; Bartelink H; Overgaard M; van Tienhoven G; Andersen KW; Sylvester RJ; van Dongen JA;
J Clin Oncol; 2001 Mar; 19(6):1688-97. PubMed ID: 11250998
[TBL] [Abstract][Full Text] [Related]
7. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy.
Schnitt SJ; Abner A; Gelman R; Connolly JL; Recht A; Duda RB; Eberlein TJ; Mayzel K; Silver B; Harris JR
Cancer; 1994 Sep; 74(6):1746-51. PubMed ID: 8082077
[TBL] [Abstract][Full Text] [Related]
8. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy.
Gage I; Schnitt SJ; Nixon AJ; Silver B; Recht A; Troyan SL; Eberlein T; Love SM; Gelman R; Harris JR; Connolly JL
Cancer; 1996 Nov; 78(9):1921-8. PubMed ID: 8909312
[TBL] [Abstract][Full Text] [Related]
9. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
[TBL] [Abstract][Full Text] [Related]
10. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
Bartelink H; Maingon P; Poortmans P; Weltens C; Fourquet A; Jager J; Schinagl D; Oei B; Rodenhuis C; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan D; Dubois JB; Remouchamps V; Mirimanoff RO; Collette S; Collette L;
Lancet Oncol; 2015 Jan; 16(1):47-56. PubMed ID: 25500422
[TBL] [Abstract][Full Text] [Related]
11. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.
Freedman G; Fowble B; Hanlon A; Nicolaou N; Fein D; Hoffman J; Sigurdson E; Boraas M; Goldstein L
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1005-15. PubMed ID: 10421533
[TBL] [Abstract][Full Text] [Related]
12. Risk factors in breast-conservation therapy.
Borger J; Kemperman H; Hart A; Peterse H; van Dongen J; Bartelink H
J Clin Oncol; 1994 Apr; 12(4):653-60. PubMed ID: 8151313
[TBL] [Abstract][Full Text] [Related]
13. Extent of margin positivity as a predictor for local recurrence after breast conserving irradiation.
Wazer DE; Jabro G; Ruthazer R; Schmid C; Safaii H; Schmidt-Ullrich RK
Radiat Oncol Investig; 1999; 7(2):111-7. PubMed ID: 10333252
[TBL] [Abstract][Full Text] [Related]
14. The relationship between findings on pre-treatment mammograms and local recurrence after breast-conserving therapy for invasive breast cancer.
Voogd AC; van der Horst F; Crommelin MA; Peterse JL; van Beek MW; Repelaer van Driel OJ; van der Heijden LH; Coebergh JW
Eur J Surg Oncol; 1999 Jun; 25(3):273-9. PubMed ID: 10336807
[TBL] [Abstract][Full Text] [Related]
15. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
[TBL] [Abstract][Full Text] [Related]
16. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.
Whelan TJ; Lada BM; Laukkanen E; Perera FE; Shelley WE; Levine MN
Cancer Prev Control; 1997 Aug; 1(3):228-40. PubMed ID: 9765748
[TBL] [Abstract][Full Text] [Related]
17. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
[TBL] [Abstract][Full Text] [Related]
18. A comparison of a brachytherapy and an external beam radiotherapy boost in breast-conserving therapy for breast cancer: local and any recurrences.
Kindts I; Verhoeven K; Laenen A; Christiaens M; Janssen H; Van der Vorst A; Van Limbergen E; Weltens C
Strahlenther Onkol; 2019 Apr; 195(4):310-317. PubMed ID: 30603857
[TBL] [Abstract][Full Text] [Related]
19. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
[TBL] [Abstract][Full Text] [Related]
20. Microscopic residual disease is a risk factor in the primary treatment of breast cancer.
Schuck A; Könemann S; Heinen K; Rübe CE; Hesselmann S; Reinartz G; Schüller P; Micke O; Schäfer U; Willich N
Strahlenther Onkol; 2002 Jun; 178(6):307-13. PubMed ID: 12122786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
